Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of intravenous NGGT002 in adults with phenylketonuria
CTR20241545Phase 2Active
- Sponsor
- Nuojiebei Biotech
- Start
- Jul 2024
- Modality
- AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of NGGT002 in phenylketonuria (PKU), sponsored by Nuojiebei Biotech. Started Jul 2024; status: active.
02
Drugs
NGGT002
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on CTR20241545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241545.